Trial Profile
Preventive effect of proton-pump inhibitor for upper gastrointestinal injury induced by low-dose aspirin in patients with ischemic stroke.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Rabeprazole (Primary) ; Famotidine
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- Acronyms JSAT
- 05 Jun 2016 Status changed from recruiting to discontinued.
- 31 Dec 2009 New trial record